Similar articles

• Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

  Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad; ICoNA Study Group. Cicconi P, et al. AIDS. 2007 Mar 12;21(5):599-606. doi: 10.1097/QAD.0b013e328013db9c. AIDS. 2007. PMID: 17314522
• Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.

  Torti C, Lapadula G, Uccelli MC, Quiros-Roldan E, Regazzi M, Ladisa N, Micheli V, Orani A, Patroni A, Caputo SL, Tirelli V, Di Giambenedetto S, Cologni G, Costarelli S, Gargiulo F, Manca N, Carosi G; RADAR Study Group of MASTER Cohort. Torti C, et al. Int J Antimicrob Agents. 2007 Feb;29(2):185-90. doi: 10.1016/j.ijantimicag.2006.08.015. Epub 2006 Oct 2. Int J Antimicrob Agents. 2007. PMID: 17011754
• Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.

  Moore E, Beadsworth MB, Chaponda M, Mhango B, Faragher B, Njala J, Hofland HW, Davies J, Hart IJ, Beeching NJ, Zijlstra EE, van Oosterhout JJ. Moore E, et al. J Infect. 2010 Jul;61(2):155-63. doi: 10.1016/j.jinf.2010.04.009. Epub 2010 May 12. J Infect. 2010. PMID: 20470823
• [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].

  Halota W, Pawłowska M. Halota W, et al. Przegl Epidemiol. 2002;56 Suppl 5:41-5. Przegl Epidemiol. 2002. PMID: 15553071 Review. Polish.
• Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment.

  Vallet-Pichard A, Pol S. Vallet-Pichard A, et al. J Hepatol. 2004 Jul;41(1):156-66. doi: 10.1016/j.jhep.2004.05.001. J Hepatol. 2004. PMID: 15246224 Review. No abstract available.